Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen. Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ Acta Pharm Sin B 14 (2024) 1605–1623J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2791-2793. DOI: 10.1016/j.apsb.2024.04.008
|
Citation:
|
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen. Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ Acta Pharm Sin B 14 (2024) 1605–1623J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2791-2793. DOI: 10.1016/j.apsb.2024.04.008
|
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen. Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ Acta Pharm Sin B 14 (2024) 1605–1623J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2791-2793. DOI: 10.1016/j.apsb.2024.04.008
|
Citation:
|
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen. Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ Acta Pharm Sin B 14 (2024) 1605–1623J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2791-2793. DOI: 10.1016/j.apsb.2024.04.008
|